Niaspan Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis
Condition:   Hyperphosphatemia Interventions:   Drug: Niacin;   Drug: Phosphate Binder Sponsor:   Assiut University Not yet recruiting - verified May 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2017 Category: Research Source Type: clinical trials

A randomized pilot study on the effect of niacin on pulmonary arterial pressure
Conclusions A single dose of immediate-release niacin (100 mg or 500 mg) had no significant effect on RVSP 1 hour post administration. A nonsignificant dose-dependent trend for a modest reduction in RVSP, most notable in the 500 mg group, was noted. (ISRCTN number 12353191, registered April 23, 2015). (Source: Trials)
Source: Trials - November 21, 2015 Category: Research Source Type: clinical trials